HEALTH

Supplement may reduce gestational diabetes risk in some women, study finds

BY Alaric DeArment

NEW YORK — A nutritional supplement may help ward off gestational diabetes in pregnant women, according to a new study.

The study, conducted by researchers at Italy’s University of Messina and published in the journal Diabetes Care, found that pregnant women with family histories of Type 2 diabetes who received myo-inositol saw a significant reduction in the incidence of gestational diabetes, a condition that causes high blood sugar in some pregnant women.

A group of 220 women was split into two halves, one of which received the supplement with 200 micrograms of folic acid twice per day, and a placebo group that only received the folic acid.

Among those who received myo-inositol, the incidence of gestational diabetes was 6%, compared with 15.3% of those in the placebo group. The researchers concluded that the supplement may reduce the incidence of gestational diabetes in women with a family history of Type 2 diabetes while also possibly reducing the risk of delivering abnormally large babies, also known as macrosomia.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Swisse Wellness launches supplement line at Walgreens

BY Alaric DeArment

NEW YORK — A line of OTC products from Australia will hit the shelves of Walgreens Friday.

Swisse Wellness announced plans to roll out its line of multivitamins and other products in October 2012, hiring actress Nicole Kidman as the spokeswoman for the brand.

An announcement on the company’s website noted that the release would coincide with Super Bowl XLVII on Sunday as it touted its Ultivite multivitamins, Swisse Ultiboost Liver Detox and Swisse Ultivite + Energy.

"Here at the new Swisse HQ in Chicago, we’re brushing up on our NFL knowledge before the big game," the announcement read. "We’re more accustomed to Aussie Rules Footy, taking in a Grand Final at the G, watching the tall timber fly for a specky or launch a screwy, shouting ‘Chewy on your boot!!’ to the opposition lining up for a sausage roll. We’ve heard NFL is a bit different. But from what we’ve learned so far, there are a few things our football games have in common: this is a time to catch up with friends, eat lots of food, and cheer on your team!"


Find us on Facebook for even more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

NCPDP releases updated acetaminophen white paper

BY Alaric DeArment

SCOTTSDALE, Ariz. — A standards-development organization for the pharmacy services industry has updated a white paper on protecting consumers and patients from accidental overdoses of the painkiller acetaminophen.

The NCPDP announced the updated white paper, "NCPDP Recommendations for Improved Prescription Container Labels for Medicines Containing Acetaminophen Version 1.1."

The NCPDP mobilized healthcare industry participants in 2011 to explore the issue of acetaminophen overdose, recommending that the industry implement measures to help patients avoid overdoses by enabling them to identify when their prescription medicines contain the drug, compare active ingredients on OTC and prescription drug labels and avoid the use of multiple medicines containing acetaminophen. Such pharmacy retailers as Walgreens, CVS, Rite Aid, Walmart and Target have implemented or committed to phased implementation of the NCPDP’s recommendations to produce prescription labels with the complete spelling of acetaminophen and eliminate use of such abbreviations as "acet" and "APAP" while prioritizing the standard acetaminophen warning label in the top-three warnings for prescription medicines.

"Liver injury from acetaminophen overdose remains a serious public health problem," FDA Center for Drug Evaluation and Research director Janet Woodcock said. "NCPDP’s leadership in working with the pharmacy system industry to develop and implement these voluntary standards continues to be an effective complement to FDA’s regulatory and educational efforts to improve the safe use of acetaminophen-containing medicines."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?